Defunct Company
Total Trials
18
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,630
NCT00369616
Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2003
Completion: Oct 31, 2005
NCT00500786
Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb
Phase: Phase 1/2
Start: Nov 30, 2004
Completion: Apr 30, 2007
NCT00652223
Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy
Start: Mar 31, 2005
Completion: Nov 30, 2005
NCT00293904
Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy
Start: Feb 28, 2006
Completion: Feb 28, 2007
NCT00574704
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
Start: Sep 30, 2006
Completion: Mar 31, 2008
NCT00574223
Start: Nov 30, 2007
Completion: Mar 31, 2009
NCT00575003
Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
Start: Dec 31, 2007
NCT00701649
Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension
Start: Mar 31, 2008
Completion: Nov 30, 2009
NCT00651703
Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients
Start: Apr 30, 2008
Completion: Jul 31, 2010
NCT00710372
Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension
Start: Jun 30, 2008
Completion: Nov 30, 2010
NCT00800332
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
Start: Nov 30, 2008
NCT00890734
CYT003-QbG10 for Treatment of Allergic Asthma Bronchial
Start: Apr 30, 2009
NCT00924105
Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes
Phase: Phase 1
Start: Jun 30, 2009
Completion: Nov 30, 2011
NCT01673672
CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma
Start: Nov 30, 2012
Completion: May 31, 2014
NCT02087644
CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
Start: May 31, 2014
Completion: Not specified